Abstract
Objectives. To describe the standardization of molecular detection and frequency of a growth hormone receptor gene deleted for exon three (GHRd3) polymorphism in a population of Peruvian children with idiopathic short stature. Materials and methods. Peripheral blood samples were used from patients (N=64) who were diagnosed with idiopathic short stature and were treated at the endocrinology unit of the National Institute of Child Health in Peru The amplification of exon 3 was carried out using G1, G2, and G3 primers by optimizing PCR conditions, such as annealing temperature and magnesium concentration. Results. The specificity of primers was maximized at 67 °C and there were no differences between magnesium concentration tests. Two-thirds (67%) of patients were GHRfl homozygous, 28% were heterozygous, and 5% were GHRd3 homozygous. Conclusions. The test was useful in determining the genotypes of patients with idiopathic short stature and revealed that only 5% had a genotype that would respond better to rhGH treatment. Thus, molecular assays may be useful when considering the decision to start drug therapy.
Translated title of the contribution | GHRd3 polymorphism of growth hormone receptor gen in peruvian children with idiopathic short stature |
---|---|
Original language | Spanish |
Pages (from-to) | 45-50 |
Number of pages | 6 |
Journal | Revista Peruana de Medicina de Experimental y Salud Publica |
Volume | 33 |
Issue number | 1 |
DOIs | |
State | Published - 1 Jan 2016 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2016, Instituto Nacional de Salud. All Rights Reserved.